维普期刊资源整合服务平台（V6.5）

109篇 您的检索式：作者名="Cohen EE"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	吉非替尼结合化放疗治疗局部晚期头颈癌显示文摘该文旨在评价表皮生长因子受体抑制剂吉非替尼结合同期放化疗治疗局部晚期头颈癌(LA—HNC)的效果及毒性.研究治疗效果和EGFR基因拷贝数目的关系。方法:Ⅲ-Ⅳ期LA—HNC患者先行卡铂及紫杉醇诱导化疗,再给以5-FU及羟基脲(FHX)同期放化疗。同时给以吉非替尼,持续2a。初步疗效终点为肿瘤临床CR。EGFR基因的拷贝数应用荧光原位杂交确定。	Cohen EE Haraf DJ Kunnavakkam R	2010	中国口腔颌面外科杂志2010，8，4：	10
2	Axitinib is an active treatment for all histologic subtypes of advanced thyroid 显示文摘	Cohen EE Rosen LS Vokes EE	2008	Journal of Clinical Oncology2008，26，29：	1
3	Preferrenfial cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells 显示文摘	Pel-Hu liao Wen-Kang Cohen	2000	Cancer Lettors2000，153，12：	1
4	Current treatment options for metastatic head and neck cancer显示文摘	Price KA Cohen EE	2012	Curr Treat Options Oncol2012，13，1：	1
5	Cardiac tumors :diagnosis and management显示文摘	Salcedo EE Cohen GL White RD	1992	Curr Probl Cardiol1992，17，2：	1
6	An open-label single-arm,phaseⅡtrial of zalutumumab,a human monoclonal anti-EGFR antibody,in patients with platinum-refractory squamous cell carcinoma of the head and neck显示文摘	Saloura V Cohen EE Licitra L	2014	Cancer Chemother Pharmacol2014，73，6：	1
7	A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck(HNC)显示文摘	Vokes EE Cohen EE Mauer AM	2005	J Clin Oncol2005，23，16：	1
8	State-of-the-art management of locally advanced head and neck cancer 显示文摘	Seiwert TY Cohen EE	2005	Br J Cancer2005，92，8：	1
9	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck:a phase Ⅰ/Ⅱ study显示文摘	Cohen EE Davis DW Karrison TG	2009	Lancet Oncol2009，10，3：	1
10	Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer:results from a phase Ⅱ study显示文摘	Cohen EE Rosen LS Vokes EE	2008	J Clin Oncol2008，26，29：	1
11	Epidermal growth factor receptor directed therapy in head and neck cancer显示文摘	Choong NW Cohen EE	2006	Crit Rev Oncol Hematol2006，57，1：	1
12	Chronic renal failure in children treated with methyl CCNU显示文摘	Harmon WE Cohen H J Schneeberger EE	1979	N Engl J Med1979，300，：	1
13	State-of-the-art management of locally advanced head and neck cancer显示文摘	Seiwert TY Cohen EE	2005	BrJ Cancer2005，92，8：	1
14	Phase Ⅱ trial of ZD1839in recurrent or metastatic squamous cell carcinoma of the head and neck显示文摘	Rosen F Stadler WM	2003	J Clin Oncol2003，21，10：	1
15	A phase II study of lapatinib(GW572016)in recurrent/metastatic(R/M)squamous cell carcinoma of the head and neck(SCCHN)显示文摘	Abidoye OO Cohen EE Wong SJ	2006	J Clin Oncol2006，24，18：	1
16	Cardiac tumors:diagnosis and managemnet显示文摘	Salcedo EE Cohen GI White RD	1992	Curr Probl Cardiol1992，17，2：	1
17	Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer:results from a phase Ⅱ study显示文摘	Cohen EE Rosen LS Vokes EE		0，，：	1
18	ONYX-015: Onyx Pharmaceuticals显示文摘	Cohen EE Rudin CM	2001	Curr Opin Investig Drugs2001，2，12：	1
19	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck:a phaseⅠ/Ⅱstudy显示文摘	Cohen EE Davis DW Karrison TG		0，，：	1
20	Congenital malformations of the uterus: the role of ultrasound显示文摘	Puscheek EE Cohen L	2008	Semin Reprod Med2008，26，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示